Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP61444.RACv50vV39Cz9f3FT9WVsHOLt2UqOUQKAdd6pr2pVkECo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP61444.RACv50vV39Cz9f3FT9WVsHOLt2UqOUQKAdd6pr2pVkECo130_assertion type Assertion NP61444.RACv50vV39Cz9f3FT9WVsHOLt2UqOUQKAdd6pr2pVkECo130_head.
- NP61444.RACv50vV39Cz9f3FT9WVsHOLt2UqOUQKAdd6pr2pVkECo130_assertion description "[This study provides a platform to evaluate pharmacogenetic predictors of response or severe adverse events in advanced CRC. Pharmacogenetic studies can be conducted in multicenter trials, and our findings demonstrate that with continued research, clinical]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP61444.RACv50vV39Cz9f3FT9WVsHOLt2UqOUQKAdd6pr2pVkECo130_provenance.
- NP61444.RACv50vV39Cz9f3FT9WVsHOLt2UqOUQKAdd6pr2pVkECo130_assertion evidence source_evidence_literature NP61444.RACv50vV39Cz9f3FT9WVsHOLt2UqOUQKAdd6pr2pVkECo130_provenance.
- NP61444.RACv50vV39Cz9f3FT9WVsHOLt2UqOUQKAdd6pr2pVkECo130_assertion SIO_000772 20530282 NP61444.RACv50vV39Cz9f3FT9WVsHOLt2UqOUQKAdd6pr2pVkECo130_provenance.
- NP61444.RACv50vV39Cz9f3FT9WVsHOLt2UqOUQKAdd6pr2pVkECo130_assertion wasDerivedFrom gad-20150221 NP61444.RACv50vV39Cz9f3FT9WVsHOLt2UqOUQKAdd6pr2pVkECo130_provenance.
- NP61444.RACv50vV39Cz9f3FT9WVsHOLt2UqOUQKAdd6pr2pVkECo130_assertion wasGeneratedBy ECO_0000203 NP61444.RACv50vV39Cz9f3FT9WVsHOLt2UqOUQKAdd6pr2pVkECo130_provenance.